Forty eyes in 20 patients with elevated intraocular pressure were treated with either a 0.125% betaxolol ophthalmic solution or a placebo. After 2, 4, and 6 weeks of twice-daily therapy, the eyes receiving the betaxolol had a mean percent reduction in IOP greater than that in the eyes treated only with the drug vehicle (placebo). Both solutions were well tolerated.
No takes yet. Share an insight, caveat, or question.
Ronald L. Radius (1983) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: